Cytosorbents Corp 4
4 · Cytosorbents Corp · Filed Sep 15, 2014
Insider Transaction Report
Form 4
Gunton James T.
Director
Transactions
- Sale
Common Stock
2014-09-12$0.24/sh−5,450$1,308→ 1,402,151 total(indirect: By Partnership) - Sale
Common Stock
2014-09-11$0.24/sh−25,000$6,000→ 1,407,601 total(indirect: By Partnership)
Footnotes (2)
- [F1]Sales conducted pursuant to a 10b5-1 trading plan effective as of September 9, 2014, as adopted in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended, by NJTC Investment Fund, LP, of which the Reporting Person is a partner.
- [F2]These securities are held directly by NJTC Investment Fund, LP, of which the Reporting Person is a partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, or any other purpose.